Europe Automated and Closed Cell Therapy Processing Systems Market By type (stem cell therapy, and non-stem cell therapy), By workflow (separation, expansion, apheresis, fill-finish, cryopreservation and others), By scale (Pre-commercial/R&D Scale and Commercial Scale), By Country, Opportunity Analysis and Industry Forecast, 2021 - 2027
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Automated and Closed Cell Therapy Processing Systems Market
Market Report Description
The Europe Automated And Closed Cell Therapy Processing Systems Market would witness market growth of 19.9% CAGR during the forecast period (2021-2027).
Automated and closed systems provide improved cell management capabilities and decrease the chances of errors at the time of bioprocessing. Cell therapy is widely used in numerous kinds of disorders, particularly in cancer & nervous disorders. Some other applications of cell therapy include diabetes mellitus, genetic disorders, diseases of bones and joints, cardiac disorders (myocardial infarction and heart failure), and wounds of the skin & soft tissues.
Along with that, cell therapy is utilized in the development of regenerative medicines that are an interdisciplinary domain focused on maintenance, enhancement, or restoration of cell, tissue, organ function with the help of procedures majorly associated with cell therapy.
The supportive government reimbursement policies across various nations of the region and the growing demand for advanced cell therapies and automated systems over the forecast period. Moreover, the strong facility network and workforce across various European countries is estimated to spur the growth of the regional market in the coming years. Cell therapies are widely utilized in the treatment of chronic diseases like cancer, and the increasing cases of chronic diseases would further surge the growth of the regional automated and closed cell therapy processing systems market during the forecast period.
The Germany market dominated the Europe Automated and Closed Cell Therapy Processing Systems Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $143.5 million by 2027. The UK market is experiencing a CAGR of 19% during (2021 - 2027). Additionally, the France market would expect a CAGR of 22.1% during (2021 - 2027).
Based on type, the market is segmented into stem cell therapy, and non-stem cell therapy. Based on workflow, the market is segmented into separation, expansion, apheresis, fill-finish, cryopreservation and others. Based on scale, the market is segmented into Pre-commercial/R&D Scale and Commercial Scale. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Lonza Group AG, Terumo Corporation, Cytiva (Danaher Corporation), Thermo Fisher Scientific, Inc., Miltenyi Biotec B.V. & Co. KG, Thermogenesis Holdings, Inc., Cellares Inc., Biospherix ltd., Sartorius AG, and Fresenius SE & Co. KGaA.
Scope of the Study
Market Segments Covered in the Report:
- Stem Cell Therapy
- Non-Stem Cell Therapy
- Pre-commercial/R&D Scale
- Commercial Scale
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Lonza Group AG
- Terumo Corporation
- Cytiva (Danaher Corporation)
- Thermo Fisher Scientific, Inc.
- Miltenyi Biotec B.V. & Co. KG
- Thermogenesis Holdings, Inc.
- Cellares Inc.
- Biospherix ltd.
- Sartorius AG
- Fresenius SE & Co. KGaA
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free